Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study
- PMID: 30429006
- DOI: 10.1016/j.lungcan.2018.05.007
Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study
Abstract
Background: New nodules are regularly found after the baseline round of low-dose computed tomography (LDCT) lung cancer screening. The relationship between a participant's number of new nodules and lung cancer probability is unknown.
Methods: Participants of the ongoing Dutch-Belgian Randomized Lung Cancer Screening (NELSON) Trial with (sub)solid nodules detected after baseline and registered as new by the NELSON radiologists were included. The correlation between a participant's new nodule count and the largest new nodule size was assessed using Spearman's rank correlation. To evaluate the new nodule count as predictor for new nodule lung cancer together with largest new nodule size, a multivariable logistic regression analysis was performed.
Results: In total, 705 participants with 964 new nodules were included. In 48% (336/705) of participants no nodule had been found previously during baseline screening and in 22% (154/705) of participants >1 new nodule was detected (range 1-12 new nodules). Eventually, 9% (65/705) of the participants had lung cancer in a new nodule. In 100% (65/65) of participants with new nodule lung cancer, the lung cancer was the largest or only new nodule at initial detection. The new nodule lung cancer probability did not differ significantly between participants with 1 (10% [56/551], 95%CI 8-13%) or >1 new nodule (6% [9/154], 95%CI 3-11%, P = .116). An increased number of new nodules positively correlated with a participant's largest nodule size (P < 0.001, Spearman's rho 0.177). When adjusted for largest new nodule size, the new nodule count had a significant negative association with lung cancer (odds ratio 0.59, 0.37-0.95, P = .03).
Conclusion: A participant's new nodule count alone only has limited association with lung cancer. However, a higher new nodule count correlates with an increased largest new nodule size, while the lung cancer probability remains equivalent, and may improve lung cancer risk prediction by size only.
Keywords: Early detection of cancer; Incidence screening; Lung neoplasms; Multiple pulmonary nodules.
Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.
Similar articles
-
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6. Lancet Oncol. 2016. PMID: 27283862 Clinical Trial.
-
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.Lung Cancer. 2017 Nov;113:45-50. doi: 10.1016/j.lungcan.2017.08.023. Epub 2017 Sep 1. Lung Cancer. 2017. PMID: 29110848 Clinical Trial.
-
Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.Thorax. 2018 Aug;73(8):741-747. doi: 10.1136/thoraxjnl-2017-211376. Epub 2018 Apr 16. Thorax. 2018. PMID: 29661918
-
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial.Radiology. 2024 Oct;313(1):e240535. doi: 10.1148/radiol.240535. Radiology. 2024. PMID: 39436294 Review.
-
Evaluating the Patient With a Pulmonary Nodule: A Review.JAMA. 2022 Jan 18;327(3):264-273. doi: 10.1001/jama.2021.24287. JAMA. 2022. PMID: 35040882 Review.
Cited by
-
Implementation of lung cancer screening: what are the main issues?Transl Lung Cancer Res. 2021 Feb;10(2):1050-1063. doi: 10.21037/tlcr-20-985. Transl Lung Cancer Res. 2021. PMID: 33718044 Free PMC article. Review.
-
Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis.Bioengineered. 2021 Dec;12(2):12135-12147. doi: 10.1080/21655979.2021.2004977. Bioengineered. 2021. PMID: 34787049 Free PMC article.
-
The medicinal mushroom Ganoderma lucidum prevents lung tumorigenesis induced by tobacco smoke carcinogens.Front Pharmacol. 2023 Sep 6;14:1244150. doi: 10.3389/fphar.2023.1244150. eCollection 2023. Front Pharmacol. 2023. PMID: 37745066 Free PMC article.
-
Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma.J Cancer Res Clin Oncol. 2022 Jun;148(6):1419-1428. doi: 10.1007/s00432-021-03721-4. Epub 2021 Jul 3. J Cancer Res Clin Oncol. 2022. PMID: 34218331 Free PMC article.
-
Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report.Chest. 2021 Nov;160(5):1959-1980. doi: 10.1016/j.chest.2021.07.003. Epub 2021 Jul 13. Chest. 2021. PMID: 34270965 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical